Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
SVA 3A/2B–DDX23 Antiviral Defense
2026-08-14
Li and colleagues identify a dual interaction in which host RNA helicase DDX23 restricts Senecavirus A (SVA), while viral 3A and 2B proteins use distinct caspase-linked mechanisms to reduce DDX23 protein abundance. The study combines expression genetics, pathway-inhibitor experiments, and reverse-genetics viruses to connect specific viral residues with replication, providing a framework for analyzing apoptosis-related antiviral restriction without equating pharmacological caspase inhibition with direct substrate cleavage.
-
Dinaciclib (SCH727965): Assay Workflow Guide
2026-08-14
Use Dinaciclib as a multi-CDK perturbation tool to connect cell-cycle suppression with Rb dephosphorylation, apoptosis, and quantitative phenotype changes. This workflow emphasizes dose design, orthogonal validation, and careful interpretation when translating tissue-boundary mechanics into cancer research.
-
L-Phenylephrine in Reliable Cell Assays
2026-08-13
Learn how L-Phenylephrine (SKU C3021) can support interpretable adrenergic α1A studies across viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects receptor pharmacology, sex-aware experimental design, solution handling, orthogonal readouts, and practical product selection.
-
HOBt in Amide Bond Formation: Practical Workflows
2026-08-13
HOBt supports high-fidelity amide bond formation when stereochemical integrity and mild reaction conditions matter. This guide translates its use in peptide synthesis and medicinal chemistry into executable coupling workflows, optimization checkpoints, and troubleshooting strategies informed by a glucagon receptor antagonist study.
-
Live-Dead Bacterial Staining Kit for Nanomaterials
2026-08-12
Use dual fluorescence to separate membrane-intact bacteria from membrane-compromised cells during antimicrobial nanomaterial studies. This workflow connects NucGreen dye and EthD-III staining with pH, magnetic-field, and time-course controls for more interpretable bacterial viability data.
-
Amine Chemistry Governs Lung-Selective mRNA Delivery
2026-08-12
This JACS Au study combines a systematic library of cationic polymer micelles with SHAP and multitask Gaussian Process modeling to identify how amine chemistry controls mRNA binding, cellular delivery, viability, translation, and lung distribution. Its central practical implication is that optimal delivery requires a balanced interaction with mRNA rather than simply maximizing electrostatic binding.
-
Resiquimod (R-848) Workflow for Immune Studies
2026-08-11
Resiquimod (R-848) gives researchers a practical way to activate TLR7/8 while tracking cytokine output, dendritic-cell maturation, and macrophage polarization. This guide translates the MR@CaP@HA tumor-ablation study into bench workflows for formulation screening, cancer immunotherapy research, and carefully bounded vaccine adjuvant development.
-
Polymer-Pen 3D Gold Arrays for Reproducible SERS
2026-08-11
The reference study introduces a polymer pen lithography strategy for building ordered three-dimensional gold nanoparticle cluster arrays with tunable architecture. By combining patterned polyethylenimine scaffolds with electrostatic nanoparticle assembly, the authors achieved strong SERS enhancement and low substrate-to-substrate variation while retaining structural adjustability.
-
Cycloheximide Protein Turnover Workflows
2026-08-10
Cycloheximide provides a timed translation-arrest step for protein half-life measurements, apoptosis assays, and mechanistic studies of stress responses. This guide pairs practical dosing controls with the BAK-focused findings of a recent reference study so researchers can distinguish protein-synthesis dependence from direct mitochondrial apoptosis.
-
Oridonin, NF-κB, and TAA-Induced Bone Loss
2026-08-09
Jin et al. show that oridonin counteracts thioacetamide-associated skeletal injury through two complementary mechanisms: suppressing MAPK/NF-κB-driven osteoclastogenesis and restoring BMP-2/RUNX2-related osteoblast differentiation. The study provides a preclinical framework for evaluating compounds that address both excessive bone resorption and inadequate bone formation.
-
Valemetostat (DS-3201) in EZH2 Research
2026-08-08
Valemetostat (DS-3201) is a potent EZH2-focused epigenetic tool for lymphoma models and adoptive T-cell studies. This workflow-oriented guide covers exposure design, CAR-T/TCR-T combination assays, controls, and troubleshooting for translational researchers.
-
N6-Methyl-dATP for Fidelity and Epigenetic Assays
2026-08-07
N6-Methyl-dATP enables controlled substitution experiments that reveal how adenine methylation affects polymerase activity, DNA synthesis, and nucleic-acid recognition. This article translates those capabilities into practical workflows for DNA replication fidelity studies and AML-focused methylation research, with controls and troubleshooting guidance.
-
FXR Protein Phase Separation Orchestrates β-Coronavirus Repl
2026-08-07
Li et al. (2024) identify fragile X–related (FXR) proteins as key host factors that drive the clustering of coronavirus replication organelles via liquid–liquid phase separation (LLPS). This discovery elucidates a host-mediated mechanism enabling efficient β-coronavirus proliferation and opens new avenues for targeted virology research.
-
Gepotidacin in Antibacterial Research: Novel Mechanisms and
2026-08-06
Explore how Gepotidacin, a first-in-class bacterial DNA replication inhibitor, is transforming antibacterial research and clinical strategies against resistant pathogens. Learn about its unique mechanism, real-world trial results, and advanced applications in laboratory workflows.
-
Senolytic Effects of L. plantarum DS0037 Nanovesicles in Agi
2026-08-06
The referenced study identifies exosome-like nanovesicles from Lactobacillus plantarum DS0037 as potent senolytic and senomorphic agents, selectively reducing viability and modulating gene expression in senescent cells. These findings highlight a promising, natural anti-aging approach with potential applications in skin health and senescence-targeted research.